Organogenesis Holdings
ORGO
154 hedge funds and large institutions have $178M invested in Organogenesis Holdings in 2022 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 71 increasing their positions, 34 reducing their positions, and 21 closing their positions.
109% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 34
38% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 21
5% more funds holding
Funds holding: 146 → 154 (+8)
2.92% less ownership
Funds ownership: 44.95% → 42.03% (-2.9%)
37% less capital invested
Capital invested by funds: $283M → $178M (-$105M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.44M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$4.26M |
| 3 |
Millennium Management
New York
|
+$4.2M |
| 4 |
BlackRock
New York
|
+$3.89M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$21.7M |
| 2 |
State Street
Boston,
Massachusetts
|
-$18.6M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$4.37M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$1.77M |
| 5 |
Morgan Stanley
New York
|
-$1.19M |
ORGO Hedge Fund Activity: Q3 2022 in Review
154 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q3 2022, worth a combined $178M — down 37% from $283M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ORGO positions and 21 closed out — a net gain of 8 holders — while 71 added to existing stakes and 34 trimmed.
The largest buyer was Soleus Capital Management, adding an estimated $5.44M. The largest seller was Deerfield Management, exiting entirely with an estimated $21.7M sold.
- 154 institutional investors held Organogenesis Holdings (ORGO) as of Q3 2022, up from 146 in Q2 2022.
- Funds reported $178M of Organogenesis Holdings stock for Q3 2022, down 37% quarter-over-quarter.
- 29 funds opened new Organogenesis Holdings positions in Q3 2022 and 21 closed out, a net change of +8 holders.
- The largest Organogenesis Holdings buyer in Q3 2022 was Soleus Capital Management, an estimated $5.44M added.
- The largest Organogenesis Holdings seller in Q3 2022 was Deerfield Management, an estimated $21.7M sold.
Based on aggregated 13F filings for Q3 2022.